Robin Shivnaraine, PhD, Director of Clinical Pharmacology at Aerys Biosciences, will attend the Stanford Drug Discovery Symposium (SDDS) 2026, held April 27–28, 2026, at Stanford University, California.SDDS brings together academic, industry, and investment leaders to highlight advances across the drug discovery and translational development pipeline. Dr. Shivnaraine will engage with collaborators and peers to discuss Aerys’ work advancing therapies for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH), spanning discovery through early clinical development.